Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fbxo45 joins the 'Par-4'ty in controlling apoptosis of cancer cells.

Literature DB >> 25196972

Fbxo45 joins the 'Par-4'ty in controlling apoptosis of cancer cells.

Z Wang¹, W Wei².

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2014 PMID： 25196972 PMCID： PMC4158679 DOI： 10.1038/cdd.2014.104

Source DB: PubMed Journal: Cell Death Differ ISSN： 1350-9047 Impact factor: 15.828

× No keyword cloud information.

17 in total

Review 1. Ubiquitin ligases: cell-cycle control and cancer.

Authors: Keiichi I Nakayama; Keiko Nakayama
Journal: Nat Rev Cancer Date: 2006-05 Impact factor: 60.716

Review 2. The SCF ubiquitin ligase: insights into a molecular machine.

Authors: Timothy Cardozo; Michele Pagano
Journal: Nat Rev Mol Cell Biol Date: 2004-09 Impact factor: 94.444

3. Systematic analysis and nomenclature of mammalian F-box proteins.

Authors: Jianping Jin; Timothy Cardozo; Ruth C Lovering; Stephen J Elledge; Michele Pagano; J Wade Harper
Journal: Genes Dev Date: 2004-11-01 Impact factor: 11.361

4. Characterization of estrogen-induced F-box protein FBXO45.

Authors: Kenichi Yoshida
Journal: Oncol Rep Date: 2005-08 Impact factor: 3.906

Review 5. Roles of F-box proteins in cancer.

Authors: Zhiwei Wang; Pengda Liu; Hiroyuki Inuzuka; Wenyi Wei
Journal: Nat Rev Cancer Date: 2014-04 Impact factor: 60.716

6. Fbxo45 forms a novel ubiquitin ligase complex and is required for neuronal development.

Authors: Toru Saiga; Takaichi Fukuda; Masaki Matsumoto; Hirobumi Tada; Hirotaka James Okano; Hideyuki Okano; Keiichi I Nakayama
Journal: Mol Cell Biol Date: 2009-04-27 Impact factor: 4.272

Review 7. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation.

Authors: Markus Welcker; Bruce E Clurman
Journal: Nat Rev Cancer Date: 2008-02 Impact factor: 60.716

8. Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma.

Authors: Pablo J Fernandez-Marcos; Shadi Abu-Baker; Jayashree Joshi; Anita Galvez; Elias A Castilla; Marta Cañamero; Manuel Collado; Carmen Saez; Gema Moreno-Bueno; Jose Palacios; Michael Leitges; Manuel Serrano; Jorge Moscat; Maria T Diaz-Meco
Journal: Proc Natl Acad Sci U S A Date: 2009-05-26 Impact factor: 11.205

9. Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis.

Authors: Jayashree Joshi; Pablo J Fernandez-Marcos; Anita Galvez; Ramars Amanchy; Juan F Linares; Angeles Duran; Peterson Pathrose; Michael Leitges; Marta Cañamero; Manuel Collado; Clara Salas; Manuel Serrano; Jorge Moscat; Maria T Diaz-Meco
Journal: EMBO J Date: 2008-07-24 Impact factor: 11.598

Review 10. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors: David Frescas; Michele Pagano
Journal: Nat Rev Cancer Date: 2008-06 Impact factor: 60.716

5 in total

Review 1. Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins.

Authors: Nana Zheng; Zhiwei Wang; Wenyi Wei
Journal: Int J Biochem Cell Biol Date: 2016-02-06 Impact factor: 5.085

2. CACNA1C-AS2 inhibits cell proliferation and suppresses cell migration and invasion via targeting FBXO45 and PI3K/AKT/mTOR pathways in glioma.

Authors: Tong Cao; Yue Cui; Yingying Wang; Linhui Wu; Ke Yu; Kai Chen; Jun Xia; Yuyun Li; Zhiwei Peter Wang; Jia Ma
Journal: Apoptosis Date: 2022-08-29 Impact factor: 5.561